Supernus, Inc. (SUPN) stock
SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$39.84+1.96 (+5.17%)
Close on Oct 19, 2026Market cap $4.86BP/E 11.2Yield –
Supernus gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Supernus's gross profit for the twelve months ending Sep 30, 2026 was $1.17B, up 22.8% year over year. For fiscal 2025 it was $994.00M, up 3.9% from the year before. The highest annual figure on record is $994.00M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $994.00M | +3.9% |
| FY2024 | Dec 31, 2024 | $957.00M | +4.1% |
| FY2023 | Dec 31, 2023 | $919.00M | +22.7% |
| FY2022 | Dec 31, 2022 | $749.00M | +12.8% |
| FY2021 | Dec 31, 2021 | $664.00M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $305.00M | +32.6% |
| Q2 FY2026 | Jun 30, 2026 | $294.00M | +17.6% |
| Q1 FY2026 | Mar 31, 2026 | $277.00M | +25.3% |
| Q4 FY2025 | Dec 31, 2025 | $292.00M | +16.8% |
| Q3 FY2025 | Sep 30, 2025 | $230.00M | -4.6% |
| Q2 FY2025 | Jun 30, 2025 | $250.00M | +13.6% |
| Q1 FY2025 | Mar 31, 2025 | $221.00M | -10.2% |
| Q4 FY2024 | Dec 31, 2024 | $250.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $241.00M | – |
| Q2 FY2024 | Jun 30, 2024 | $220.00M | – |
| Q1 FY2024 | Mar 31, 2024 | $246.00M | – |
See a number that looks wrong?